Literature DB >> 18657527

Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.

Juan P Cata1, Han-Rong Weng, Patrick M Dougherty.   

Abstract

Neuropathy is the chief dose-limiting side effect associated with the major classes of frontline cancer therapy drugs. Here the changes in behavioral responses of rats to cutaneous mechanical and thermal stimuli occurring following treatment with cisplatin and the changes in spinal neurophysiology accompanying the development of chemotherapy-induced hyperalgesia were explored. Systemic treatment with cisplatin induced changes in both mechanical and thermal cutaneous sensory withdrawal thresholds of Sprague-Dawley rats. High doses of chemotherapy produced hypoalgesia whereas lower doses produced hyperalgesia. Follow-up neurophysiological studies in rats with chemotherapy-induced hyperalgesia revealed that deep spinal lamina wide dynamic range neurons had significantly higher spontaneous activity and longer afterdischarges to noxious mechanical stimuli than wide dynamic range neurons in control rats; cisplatin administration was also associated with longer afterdischarges and abnormal wind-up to transcutaneous electrical stimuli. The hyperexcitability observed during cisplatin-induced hyperalgesia is very similar to that observed in rats with hyperalgesia produced following treatment with other very diverse types of chemotherapeutic agents and similar to that observed following specific types of direct nerve injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657527      PMCID: PMC2630495          DOI: 10.1016/j.brainres.2008.07.022

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  Sensory processing in the deep spinal dorsal horn of neurokinin-1 receptor knockout mice.

Authors:  H R Weng; H Mansikka; R Winchurch; S N Raja; P M Dougherty
Journal:  Anesthesiology       Date:  2001-06       Impact factor: 7.892

Review 2.  Chemotherapy-induced peripheral neuropathy.

Authors:  Stefan Quasthoff; Hans Peter Hartung
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

3.  Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties.

Authors:  A Pertovaara; H Wei; J Kalmari; M Ruotsalainen
Journal:  Exp Neurol       Date:  2001-02       Impact factor: 5.330

4.  A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel.

Authors:  Rosemary C Polomano; Andrew J Mannes; Uraina S Clark; Gary J Bennett
Journal:  Pain       Date:  2001-12       Impact factor: 6.961

5.  Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury.

Authors:  Chang-Ning Liu; Patrick D Wall; Efrat Ben-Dor; Martin Michaelis; Ron Amir; Marshall Devor
Journal:  Pain       Date:  2000-04       Impact factor: 6.961

6.  Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration.

Authors:  Stewart J Kellie; Draga Barbaric; Pauline Koopmans; John Earl; Deborah J Carr; Siebold S N de Graaf
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

7.  Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia.

Authors:  H-R Weng; J V Cordella; P M Dougherty
Journal:  Pain       Date:  2003-05       Impact factor: 6.961

8.  An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections.

Authors:  Nicolas Authier; Jean Pierre Gillet; Joseph Fialip; Alain Eschalier; François Coudore
Journal:  Exp Neurol       Date:  2003-07       Impact factor: 5.330

9.  Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.

Authors:  M J McKeage; T Hsu; D Screnci; G Haddad; B C Baguley
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

10.  Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin.

Authors:  Zuzana Bencokova; Laurianne Pauron; Clément Devic; Aurélie Joubert; Jérôme Gastaldo; Catherine Massart; Jacques Balosso; Nicolas Foray
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.506

View more
  31 in total

Review 1.  Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.

Authors:  Holly L Hopkins; Natalie A Duggett; Sarah J L Flatters
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

2.  Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

Authors:  Yan Li; Haijun Zhang; Hongmei Zhang; Alyssa K Kosturakis; Abdul Basit Jawad; Patrick M Dougherty
Journal:  J Pain       Date:  2014-04-19       Impact factor: 5.820

3.  Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Chinazom Ibegbu; Rachel Kitt; Jennifer Serventi; Joy Burke; Eva Culakova; Noah Kolb; Kathleen A Sluka; Mohamedtaki A Tejani; Nimish A Mohile
Journal:  Support Care Cancer       Date:  2018-08-27       Impact factor: 3.603

4.  MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

Authors:  Yan Li; Hongmei Zhang; Alyssa K Kosturakis; Ryan M Cassidy; Haijun Zhang; Ross M Kennamer-Chapman; Abdul Basit Jawad; Cecilia M Colomand; Daniel S Harrison; Patrick M Dougherty
Journal:  Brain Behav Immun       Date:  2015-06-09       Impact factor: 7.217

Review 5.  Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.

Authors:  Joyce H Kim; Patrick M Dougherty; Salahadin Abdi
Journal:  Gynecol Oncol       Date:  2015-01-10       Impact factor: 5.482

Review 6.  Pain in cancer survivors.

Authors:  Paul A Glare; Pamela S Davies; Esmé Finlay; Amitabh Gulati; Dawn Lemanne; Natalie Moryl; Kevin C Oeffinger; Judith A Paice; Michael D Stubblefield; Karen L Syrjala
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

7.  Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

Authors:  Yatendra Mulpuri; Vincent N Marty; Joseph J Munier; Ken Mackie; Brian L Schmidt; Herbert H Seltzman; Igor Spigelman
Journal:  Neuropharmacology       Date:  2018-07-05       Impact factor: 5.250

8.  The Neuroprotective Effect of Mesna on Cisplatin-Induced Neurotoxicity: Behavioral, Electrophysiological, and Molecular Studies.

Authors:  Somayeh Noroozzadeh; Hedieh Esmaeili; Hakimeh Saadati; Keyvan Amirshahrokhi; Javad Shadman; Ali Niapour
Journal:  Neurotox Res       Date:  2020-11-20       Impact factor: 3.911

9.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

Authors:  Lauren E Ta; Allan J Bieber; Susan M Carlton; Charles L Loprinzi; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

Review 10.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.